Government warns against unauthorized weight loss drugs: Ozempic, Mounjaro under scrutiny

• Union Health Ministry intensifies surveillance on unauthorized sale of GLP-1 based weight loss drugs like Ozempic and Mounjaro.
• Concerns rise as generic versions are easily available without prescription from pharmacies, online platforms, and clinics.
• Using these drugs without doctor's consultation can lead to serious side effects and health risks.
• Drug Controller issued guidelines prohibiting surrogate advertising and indirect promotion to mislead the public.
• Nationwide campaign conducted inspections at 49 establishments, uncovering irregularities and leading to notices; non-compliance may result in license cancellation and legal action.